Capstone Investment Advisors (Netherlands)’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$240K Sell
1,277
-452
-26% -$81.2K 0.84% 44
2017
Q1
$286K Sell
1,729
-496
-22% -$78.9K 0.81% 47
2016
Q4
$320K Buy
+2,225
New +$298K 0.54% 40

Other funds holding ELV

Capstone Investment Advisors (Netherlands)'s ELV Position: Q2 2017 in Review

Capstone Investment Advisors (Netherlands) reduced its Elevance Health (ELV) stake by 26% in Q2 2017, selling an estimated $81.2K and leaving 1,277 shares worth $240K. The position accounts for 0.84% of the portfolio, ranked #44.

Capstone Investment Advisors (Netherlands) first reported a position in ELV in Q4 2016 and has held it in 3 quarters since. The position peaked at $320K in Q4 2016. 851 funds tracked by Wall St. Rank hold ELV as of Q2 2017.

  • Capstone Investment Advisors (Netherlands) held 1,277 shares of Elevance Health worth $240K as of Q2 2017.
  • Capstone Investment Advisors (Netherlands) sold 452 Elevance Health shares in Q2 2017, an estimated $81.2K.
  • Elevance Health made up 0.84% of Capstone Investment Advisors (Netherlands)'s portfolio in Q2 2017, its #44 holding.
  • Capstone Investment Advisors (Netherlands) first reported a position in Elevance Health in Q4 2016 and has held it in 3 quarters since.
  • Capstone Investment Advisors (Netherlands)'s Elevance Health position peaked at $320K in Q4 2016.
  • 851 funds tracked by Wall St. Rank held Elevance Health as of Q2 2017.

Based on Capstone Investment Advisors (Netherlands)'s 13F filing for Q2 2017, filed 14 Aug 2017.